Rabbit calvarial wound healing by means of seeded Caprotite® scaffolds

Journal of Dental Research

Volumn 82, Issue 2, 2003, Pages 131-135

  Bidic, S M S ^a   Calvert, J W ^b   Marra, K ^c   Kumta, P ^c   Campbell, P ^c   Mitchell, R ^a   Wigginton, W ^a   Hollinger, J O ^a,c   Weiss, L ^d   Mooney, M P ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CARNEGIE MELLON UNIVERSITY   (United States)

^d CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

Bone cells; Calvaria; Caprotite ; Rabbits; Scaffolds

Indexed keywords

ANALYSIS OF VARIANCE; ANIMAL; ANIMAL MODEL; ARTICLE; BIODEGRADABLE IMPLANT; BONE MARROW TRANSPLANTATION; BONE PROSTHESIS; BONE REGENERATION; BONE TRANSPLANTATION; COMPARATIVE STUDY; EVALUATION; IMPLANT; MALE; NONPARAMETRIC TEST; RABBIT; SKULL; TISSUE ENGINEERING; WOUND HEALING;

ABSORBABLE IMPLANTS; ANALYSIS OF VARIANCE; ANIMALS; BONE MARROW TRANSPLANTATION; BONE REGENERATION; BONE SUBSTITUTES; BONE TRANSPLANTATION; IMPLANTS, EXPERIMENTAL; MALE; MODELS, ANIMAL; PARIETAL BONE; RABBITS; STATISTICS, NONPARAMETRIC; TISSUE ENGINEERING; WOUND HEALING;

EID: 0037313102     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910308200211     Document Type: Article

References (24)

1. Bonadio J, Smiley E, Patil P, Goldstein S (1999). Localized, direct plasmid gene therapy in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med 5:753-759.
2. Calvert JW, Marra KG, Cook L, Kumpta PN, DiMilla PA, Weiss LE (2000). Characterization of osteoblast-like behavior of cultured bone marrow stromal cells on various polymer surfaces. J Biomed Mater Res 52:279-284.
3. Chakkalakal DA, Strates BS, Garvin KL, Novak JR, Fritz ED, Mollner TJ, et al. (2001). Demineralized bone matrix as a biological scaffold for bone repair. Tissue Eng 7:161-177.
4. de Bruijn JD, van den Brink I, Mendes S, Dekker R, Bovell YP, van Blitterswijk CA (1999). Bone induction by implants coated with cultured osteogenic bone marrow cells. Adv Dent Res 13:74-81.
5. Einhorn TA, Lee CA (2001). Bone regeneration: new findings and potential clinical applications. J Am Acad Orthop Surg 9:157-165.
6. Goldstein AS, Zhu G, Morris GE, Meszlenyi RK, Mikos AG (1999). Effect of osteoblastic culture conditions on the structure of poly(DL-lactic-co-glycolic acid) foam scaffolds. Tissue Eng 5:421-434.
7. Hollinger JO, Kleinschmidt JC (1990). The critical size defect as an experimental model to test bone repair materials. J Craniofac Surg 1:60-68.
8. Hutmacher DW (2001). Scaffold design and fabrication technologies for engineering tissues - state of the art future perspectives. J Biomater Sci Polym Ed 12:107-124.
9. Ignatius AA, Wolf S, Augat P, Claes LE (2001). Composites made of rapidly resorbable ceramics and poly(lactide) show adequate mechanical properties for use as bone substitute materials. J Biomed Mater Res 57:126-131.
10. Liljensten EL, Attaelmanan AG, Larsson C, Ljusberg-Wahren H, Danielsen N, Hirsch JM, et al. (2000). Hydroxyapatite granule/carrier composites promote new bone formation in cortical defects. Clin Implant Dent Relat Res 2:50-59.
11. Ma PX, Zhang R, Xiao G, Franceschi R (2001). Engineering new bone tissue in vitro on highly porous poly(alpha-hydroxyl acids)/hydroxyapatite composite scaffolds. J Biomed Mater Res 54:284-293.
12. Mackenzie DJ, Sipe R, Buck D, Burgess W, Hollinger J (2001). Recombinant human acidic fibroblast growth factor and fibrin carrier regenerates bone. Plast Reconstr Surg 107:989-996.
13. Marra KG, Szem JW, Kumta PN, DiMilla PA, Weiss LE (1999a). In vitro analysis of biodegradable polymer blend/hydroxyapatite composites for bone tissue engineering. J Biomed Mater Res 47:324-335.
14. Marra KG, Campbell PG, DiMilla PA, Kumta PN, Mooney MP, Szem JW, et al. (1999b). Novel three-dimensional biodegradable scaffolds for bone tissue engineering. In: Biomedical materials: drug delivery, implants, and tissue engineering. Proceedings of the Materials Research Society Symposium, Nov 5-9, 1999, Boston, MA. Vol. 550. Neenan T, Marcolongo M, Valentini RF, editors. Boston, MA: Material Research Society, pp. 155-160.
15. Mayr-Wohlfart U, Fiedler J, Gunther KP, Puhl W, Kessler S (2001). Proliferation and differentiation rates of human osteoblast-like cell line (SaOS-2) in contact with different bone substitute materials. J Biomed Mater Res 57:132-139.
16. Mikos AG, Sarakinos G, Vacanti JP, Langer RS, Cima LG, inventors (1996). Biocompatible polymer membranes and methods of preparation of three-dimensional membrane structures. US patent, 5,514,378.
17. Murphy WL, Peters MC, Kohn DH, Mooney DJ (2000). Sustained release of vascular endothelial growth factor from mineralized poly (lactide-co-glycolide scaffolds for tissue engineering. Biomaterials 21:2521-2527.
18. Pilliar RM, Filiaggi MJ, Wells JD, Grynpas MD, Kandel RA (2001). Porous calcium phosphate scaffolds for bone substitute applications - in vitro characterization. Biomaterials 22:963-972.
19. Service RF (2000). Bone remodeling and repair. Science 289:1421-1640.
20. Shea LD, Wang D, Franceschi RT, Mooney DJ (2000). Engineered bone development from pre-osteoblast cell line on three-dimensional scaffolds. Tissue Eng 6:605-617.
21. Whang K, Healy KE, Elenz DR, Nam EK, Tsai DC, Thomas CH, et al. (1999). Engineering bone regeneration with bioabsorbable scaffolds with novel microarchitecture. Tissue Eng 5:35-51.
22. Winn SR, Uludag H, Hollinger JO (1999a). Carrier systems for bone morphogenetic proteins. Clin Orthop 367(Suppl):S95-S106.
23. Winn SR, Randolph G, Uludag H, Wong SC, Hair GA, Hollinger JO (1999b). Establishing an immortalized human osteoprecursor cell line: OPC1. J Bone Min Res 14:1721-1733.
24. Winn SR, Hu Y, Sfeir C, Hollinger JO (2000). Gene therapy approaches for modulating bone regeneration. Adv Drug Deliv Rev 42:121-138.